SCM

Sio Capital Management Portfolio holdings

AUM $604M Turnover 53.26%
1-Year Est. Return 96.57%
This Fund
S&P 500
This Quarter Est. Return
+8%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$181M
AUM Growth
+$14.5M
Cap. Flow
+$68.4K
Cap. Flow %
0.04%
Top 10 Hldgs %
46.73%
Holding
61
New
30
Increased
7
Reduced
10
Closed
12
Avg Time Held Equity + Options
0.3 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
0.3 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$7.19M
2
CI icon
Cigna
CI
+$6.79M
3
HUM icon
Humana
HUM
+$5.21M
4
RIGL icon
Rigel Pharmaceuticals
RIGL
+$4.98M
5
HCA icon
HCA Healthcare
HCA
+$4.54M

Top Sells

Rank Stock Value
1
GYRE icon
Gyre Therapeutics
GYRE
+$15.9M
2
SNY icon
Sanofi
SNY
+$10.2M
3
BIIB icon
Biogen
BIIB
+$8.73M
4
VKTX icon
Viking Therapeutics
VKTX
+$6.62M
5
LLY icon
Eli Lilly
LLY
+$6.37M

Sector Composition

Rank Sector Weight
1 Healthcare 83.09%
2 Miscellaneous 10.77%
3 Financials 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
KURA icon
1
Kura Oncology
KURA
$855M
$15.2M 8.43%
837,604
+180,193
+27% +$3.05M
2017 Q3
3 quarters
ELV icon
2
Elevance Health
ELV
$92.8B
$10.4M 5.74%
43,601
-8,786
-17% -$2.03M
2017 Q2
4 quarters
HCA icon
3
HCA Healthcare
HCA
$102B
$9.98M 5.52%
97,230
+44,900
+86% +$4.54M
2018 Q1
1 quarter
LITS icon
4
Lite Strategy Inc
LITS
$35.6M
$8.61M 4.76%
109,199
+62,471
+134% +$3.83M
2017 Q4
2 quarters
ICLR icon
5
Icon
ICLR
$13B
$7.33M 4.05%
55,332
+19,132
+53% +$2.38M
2017 Q3
3 quarters
AET
6
DELISTED
Aetna Inc
AET
$7.18M 3.97%
39,135
+7,500
+24% +$1.34M
2016 Q4
6 quarters
DB icon
7
PUT
Deutsche Bank
DB
$61.6B
$6.95M 3.84%
+654,800
New +$8.35M
2018 Q2
0 quarters
CI icon
8
Cigna
CI
$76.5B
$6.66M 3.68%
+39,200
New +$6.79M
2018 Q2
0 quarters
CAH icon
9
Cardinal Health
CAH
$57.4B
$6.19M 3.42%
+126,770
New +$7.19M
2018 Q2
0 quarters
SNY icon
10
Sanofi
SNY
$95.3B
$6M 3.32%
150,058
-258,563
-63% -$10.2M
2018 Q1
1 quarter
BSX icon
11
Boston Scientific
BSX
$62.3B
$5.97M 3.3%
182,633
-42,830
-19% -$1.29M
2017 Q4
2 quarters
GYRE icon
12
Gyre Therapeutics
GYRE
$686M
$5.5M 3.04%
62,860
-90,472
-59% -$15.9M
2017 Q2
4 quarters
HUM icon
13
Humana
HUM
$51.3B
$5.3M 2.93%
+17,793
New +$5.21M
2018 Q2
0 quarters
PHG icon
14
Philips
PHG
$24.4B
$4.3M 2.38%
131,075
+29,974
+30% +$958K
2016 Q1
9 quarters
NVS icon
15
Novartis
NVS
$279B
$4.16M 2.3%
+61,380
New +$4.24M
2018 Q2
0 quarters
RIGL icon
16
Rigel Pharmaceuticals
RIGL
$875M
$3.96M 2.19%
+139,862
New +$4.98M
2018 Q2
0 quarters
WTW icon
17
Willis Towers Watson
WTW
$27.6B
$3.94M 2.18%
+25,969
New +$3.95M
2018 Q2
0 quarters
UHS icon
18
Universal Health Services
UHS
$11B
$3.94M 2.18%
+35,323
New +$4.14M
2018 Q2
0 quarters
RVTY icon
19
Revvity
RVTY
$17B
$3.85M 2.13%
+52,620
New +$3.95M
2018 Q2
0 quarters
PFE icon
20
PUT
Pfizer
PFE
$166B
$3.63M 2.01%
+105,400
New +$3.6M
2018 Q2
0 quarters
VTRS icon
21
CALL
Viatris
VTRS
$20B
$3.61M 2%
+100,000
New +$3.92M
2018 Q2
0 quarters
ECOR icon
22
electroCore
ECOR
$73.9M
$3.52M 1.95%
+14,241
New +$3.87M
2018 Q2
0 quarters
CELG
23
DELISTED
Celgene Corp
CELG
$3.33M 1.84%
41,942
+10,762
+35% +$894K
2018 Q1
1 quarter
SPPI
24
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$3.01M 1.66%
+143,550
New +$2.66M
2018 Q2
0 quarters
MRTX
25
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.96M 1.64%
+60,050
New +$2.27M
2018 Q2
0 quarters
1
2 3

Similar funds

EFL
ERn Financial LLC Middleton, Wisconsin $604M AUM 19.83% 1-Year Est. Return
V
VeraBank Henderson, Texas $604M AUM 23.32% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $604M AUM 72.61% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $604M AUM 64.38% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $605M AUM
VCP
Varenne Capital Partners Paris, France $603M AUM 46.34% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Sio Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Sio Capital Management held 61 positions worth $181M, up 8.7% from $166M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sio Capital Management's Q2 2018 filing shows 30 new, 7 increased, 10 reduced and 12 closed positions. Its largest new stake was Cardinal Health: 126,770 shares worth $6.19M. The largest sale was Gyre Therapeutics, an estimated $15.9M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 93% a quarter earlier, followed by Miscellaneous and Financials.

  • Sio Capital Management's largest Q2 2018 buy was Cardinal Health: 126,770 shares worth $6.19M.
  • Sio Capital Management added most to HCA Healthcare in Q2 2018, an estimated $4.54M increase.
  • Sio Capital Management's biggest Q2 2018 reduction was Gyre Therapeutics, cutting an estimated $15.9M.
  • Sio Capital Management fully exited Biogen in Q2 2018, selling an estimated $8.73M.
  • Sio Capital Management's ten largest holdings make up 47% of its $181M portfolio in Q2 2018.
  • Sio Capital Management opened 30 new positions and closed 12 in Q2 2018.
  • Sio Capital Management's portfolio value rose 8.7% quarter-over-quarter to $181M.

Based on Sio Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.